What is Abubakr Bajwa's NPI number?

Abubakr Bajwa's National Provider Identifier (NPI) is 1467442392, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Abubakr Bajwa's specialty?

Abubakr Bajwa is listed in the NPPES registry with a primary specialty of Pulmonary Disease Physician (Allopathic & Osteopathic Physicians).

Where is Abubakr Bajwa located?

Abubakr Bajwa's practice location on file with NPPES is 4500 San Pablo Rd S, Jacksonville, FL 32224-1865.

What is Abubakr Bajwa's phone number?

The practice phone number listed in the NPPES registry for Abubakr Bajwa is (904) 953-2000.

Does Abubakr Bajwa accept Medicare?

Abubakr Bajwa is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Abubakr Bajwa's NPI active?

Yes — Abubakr Bajwa's NPI (1467442392) is active in the NPPES registry as of the last update on 2023-09-05.

IndividualActiveAccepts Medicare

Abubakr Bajwa, M.D.

NPI 1467442392 · Pulmonary Disease Physician · Jacksonville, FL

Abubakr Bajwa, M.D. is a Pulmonary Disease Physician provider in Jacksonville, FL (NPI 1467442392).

Provider details

NPI number: 1467442392
Entity type: Individual
Primary specialty: Pulmonary Disease PhysicianAllopathic & Osteopathic Physicians
Credential: M.D.
Sex: Male
Sole proprietor: No
License: ME93141 (FL)

Practice location

4500 San Pablo Rd S

Jacksonville, FL 32224-1865

Phone: (904) 953-2000

Street-level locationGet directions

More FL providers

Mailing address

4500 San Pablo Rd S

Jacksonville, FL 32224-1865

Specialties & taxonomies

Pulmonary Disease PhysicianPrimary207RP1001XLicense ME93141 (FL)
Allopathic & Osteopathic Physicians

Additional practice locations (1)

3 Shircliff Way Ste 625
Jacksonville, FL 32204-4776
Phone: (904) 308-6900

Enrolled with Medicare as Practitioner - Pulmonary Disease · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(97/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
21 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
2 documented practice locations
Medicare service volume (vs. specialty peers)25% of score
4,367 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Test to Examine How Well the Lungs Exchange Gases94729	886	$52
Test to Measure Expiratory Airflow and Volume94010	787	$24
Test to Determine Lung Volumes Using Sensors94726	661	$52
Test to Measure Expiratory Airflow and Volume Changes Before and After Medication Administration94060	368	$36
Test for Exercise-Induced Lung Stress94618	235	$11
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	232	$123

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 16 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Fluticasone/Umeclidin/Vilanterbrand: Trelegy Ellipta	75	20
Nintedanib Esylatebrand: Ofev	60	12
Azithromycin	39	25
Prednisone	39	20
Albuterol Sulfatebrand: Albuterol Sulfate Hfa	33	23
Montelukast Sodium	29	—
Treprostinilbrand: Tyvaso Dpi

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$6,160 across 30 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2005-10-22
Last updated: 2023-09-05
Certified: 2023-09-05

Frequently asked questions

What is Abubakr Bajwa's NPI number?: Abubakr Bajwa's National Provider Identifier (NPI) is 1467442392, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Abubakr Bajwa's specialty?: Abubakr Bajwa is listed in the NPPES registry with a primary specialty of Pulmonary Disease Physician (Allopathic & Osteopathic Physicians).
Where is Abubakr Bajwa located?: Abubakr Bajwa's practice location on file with NPPES is 4500 San Pablo Rd S, Jacksonville, FL 32224-1865.
What is Abubakr Bajwa's phone number?: The practice phone number listed in the NPPES registry for Abubakr Bajwa is (904) 953-2000.
Does Abubakr Bajwa accept Medicare?: Abubakr Bajwa is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Abubakr Bajwa's NPI active?: Yes — Abubakr Bajwa's NPI (1467442392) is active in the NPPES registry as of the last update on 2023-09-05.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Test to Examine How Well the Lungs Exchange Gases94729	886	$52
Test to Measure Expiratory Airflow and Volume94010	787	$24
Test to Determine Lung Volumes Using Sensors94726	661	$52
Test to Measure Expiratory Airflow and Volume Changes Before and After Medication Administration94060	368	$36
Test for Exercise-Induced Lung Stress94618	235	$11
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	232	$123

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 16 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Fluticasone/Umeclidin/Vilanterbrand: Trelegy Ellipta	75	20
Nintedanib Esylatebrand: Ofev	60	12
Azithromycin	39	25
Prednisone	39	20
Albuterol Sulfatebrand: Albuterol Sulfate Hfa	33	23
Montelukast Sodium	29	—
Treprostinilbrand: Tyvaso Dpi

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$6,160 across 30 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Additional practice locations (1)

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Additional practice locations (1)

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments